Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SRPT
Recent news which mentions SRPT
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
EWTX
RETA
SPX
From
MarketWatch
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Tickers
BLPH
CBIO
CPHI
CUTR
Tags
SDGR
SRPT
TSVT
From
Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
Tickers
NFE
NNI
NRDY
NSTG
Tags
ZVIA
SILK
RYAN
From
Benzinga
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Tickers
SRPT
Tags
Benzinga
SRPT
BZI/AAR
From
Benzinga
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
Tickers
CRSP
GNOM
MYGN
NTLA
Tags
SRPT
NASDAQ:CRSP,NASDAQ:GNOM,NASDAQ:NTLA,NASDAQ:MYGN,NASDAQ:SRPT
Market News
From
InvestorPlace
9 Analysts Have This to Say About Sarepta Therapeutics
January 20, 2023
Tickers
SRPT
Tags
Benzinga
SRPT
BZI/AAR
From
Benzinga
7 Biotech Stocks That Will Make You Rich in 10 Years
January 18, 2023
Tickers
ABBV
CRSP
CVAC
DIS
Tags
DIS
CRSP
Market News
From
InvestorPlace
2 Under-the-Radar Biotech Stocks to Buy in 2023
January 06, 2023
Tickers
CRSP
SRPT
VRTX
Tags
Market News
CRSP
SRPT
From
Motley Fool
BTIG Maintains Buy Rating for Sarepta Therapeutics: Here's What You Need To Know
December 22, 2022
Tickers
SRPT
Tags
BZI/AAR/UPDATE
Benzinga
SRPT
From
Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
Tickers
AZN
GH
SRPT
Tags
GH
Recent Press Releases
SRPT
From
Motley Fool
Analyst Ratings for Sarepta Therapeutics
November 03, 2022
Tickers
SRPT
Tags
Benzinga
SRPT
BZI/AAR
From
Benzinga
Sarepta Therapeutics (SRPT) Q3 2022 Earnings Call Transcript
November 03, 2022
Tickers
SRPT
Tags
Recent Press Releases
SRPT
Market News
From
Motley Fool
Earnings Scheduled For November 2, 2022
November 02, 2022
Tickers
QMCO
QRVO
RACE
RARE
Tags
VCYT
SHEN
SU
From
Benzinga
3 Unstoppable Stocks That Could Double in 5 Years
October 29, 2022
Tickers
DNA
NVCR
SRPT
Tags
SRPT
Recent Press Releases
DNA
From
Motley Fool
2 Under-the-Radar Biotech Stocks to Buy in 2022
October 19, 2022
Tickers
CRSP
SRPT
Tags
CRSP
Market News
SRPT
From
Motley Fool
Apple To $177? Plus This Analyst Slashes PT On Opendoor Technologies By About 71%
October 17, 2022
Tickers
AAPL
BILL
LIN
OPEN
Tags
Analyst Ratings
LIN
Benzinga
From
Benzinga
7 Analysts Have This to Say About Sarepta Therapeutics
October 13, 2022
Tickers
SRPT
Tags
SRPT
Benzinga
Market News
From
Benzinga
PepGen's Duchenne Candidate Has Potential For Greater Exon Skipping Capabilities At Lower Doses Versus Sarepta's Candidate, Says Analyst
September 28, 2022
Tickers
PEPG
SRPT
Tags
News
Trading Ideas
Analyst Color
From
Benzinga
$6 Million Bet On Sarepta Therapeutics? 3 Stocks Insiders Are Buying
September 16, 2022
Tickers
CNA
COIN
SRPT
Tags
Insider Trades
Benzinga
Markets
From
Benzinga
Analyst Ratings for Sarepta Therapeutics
September 08, 2022
Tickers
SRPT
Tags
Benzinga
SRPT
BZI/AAR
From
Benzinga
A Biotech's Stock Just Hit Year High. This Analyst Expects It To Jump Another 16%
September 08, 2022
Tickers
SRPT
Tags
Health Care
Analyst Color
Trading Ideas
From
Benzinga
FDA Lifts Clinical Hold On Sarepta's Dose-Expansion Part Of Duchenne Trial
September 06, 2022
Tickers
SRPT
Tags
Health Care
Benzinga
General
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
August 29, 2022
Tickers
CRSP
MYGN
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Sarepta In-Licenses Next-Gen AAV Tech Covering Five Indications
August 08, 2022
Tickers
SRPT
Tags
General
Contracts
Benzinga
From
Benzinga
Is Biotech Back? This Analyst Sees 18% Upside Potential In This Bio Play
August 08, 2022
Tickers
SRPT
Tags
Gianni Di Poce
Earnings
Biotech
From
Benzinga
Sarepta's Duchenne Gene Therapy Update Gets Bullish Stance From Analysts
August 03, 2022
Tickers
SRPT
Tags
SRPT
Briefs
Price Target
From
Benzinga
Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript
August 02, 2022
Tickers
SRPT
Tags
SRPT
Recent Press Releases
Market News
From
Motley Fool
Sarepta Therapeutics: Q2 Earnings Insights
August 02, 2022
Tickers
SRPT
Tags
Earnings
Market News
BZI/Recaps
From
Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
Tickers
ABBV
ACIU
ALLR
AXLA
Tags
Movers
CLLS
RIGL
From
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Tickers
LUNG
LXRX
MAR
MCHP
Tags
RGEN
OI
TRUE
From
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.